Targeted suppression of cytokine production in monocytes but not in T lymphocytes by a tetravalent guanylhydrazone (CNI-1493)

Journal of Infectious Diseases

Volumn 176, Issue 5, 1997, Pages 1303-1312

  Björk, Lars ^b   Tracey, Kevin J ^b   Ulrich, Peter ^b   Bianchi, Marina ^b   Cohen, Pamela S ^b   Åkerlund, Karin ^b   Fehniger, Thomas E ^b   Andersson, Ulf ^b   Andersson, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; HYDRAZONE DERIVATIVE; SEMAPIMOD; UNCLASSIFIED DRUG;

ARTICLE; DRUG EFFECT; HUMAN; HUMAN CELL; IMAGE ANALYSIS; INFECTION; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030812565     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514126     Document Type: Article

References (17)

1. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471-7.
2. Gershenwald JE, Fong YM, Fahey TJ 3rd, et al. Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci USA 1990;87:4966-70.
3. Jue DM, Sherry B, Luedke C, Manogue KR, Cerami A. Processing of newly synthesized cachectin/tumor necrosis factor in endotoxin-stimulated macrophages. Biochemistry 1990;29:8371-7.
4. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994;76:253-62.
5. Cannon JG, Tompkins RG, Gelfand JA, et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990;161:79-84.
6. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin-6, interleukin-1, and fatal outcome. J Exp Med 1989;169:333-8.
7. Titus RG, Sherry B, Cerami A. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J Exp Med 1989;170:2097-104.
8. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470-4.
9. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectinTNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987;330:662-4.
10. Tracey KJ. The acute and chronic pathophysiological effects of TNF: mediation of septic shock and wasting (cachexia). In: Beutler B, ed. Tumor necrosis factors: the molecules and their emerging role in medicine. New York: Raven Press, 1992:255-73.
11. Van Dervort AL, Yan L, Madara PJ, et al. Nitric oxide regulates endotoxin-induced TNF-alpha production by human neutrophils. J Immunol 1994;152:4102-9.
12. Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 1991;173:699-703.
13. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor α by enhancing mRNA degradation. J Exp Med 1993;177:1675-80.
14. Lee JC, Laydon JT, McDonnell PC, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994;372:739-46.
15. Baydoun AR, Bogle RG, Pearson JD, Mann GE. Selective inhibition by dexamethasone of induction of NO synthase, but not of induction of L-arginine transport, in activated murine macrophage J774 cells. Br J Pharmacol 1993;110:1401-6.
16. Novogrodsky A, Vanichkin A, Patya M, Gazit A, Osherov N, Levitzki A. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 1994;264:1319-22.
17. Cobb JP, Cunnion RE, Danner RL. Nitric oxide as a target for therapy in septic shock. Crit Care Med 1993;21:1261-3.